Dyslipidemia prevalence, awareness, treatment and control in Mexico: results of the Ensanut 2012

Objective. To describe in a national sample 1) the preva­lence, awareness, treatment and control of dyslipidemias 2) the prevalence of dyslipidemias through previous national surveys. Materials and methods. We analyzed data of the National Health and Nutrition Survey 2012, a represen­tative cross-sectional study. Serum samples of 9 566 adults ≥20 years old with fasting ≥8 hours were analyzed for lipid fractions. Age-adjusted prevalences were calculated, by so­ciodemographic variables. Prevalence of awareness, treatment and control was estimated. A description of the dyslipidemia prevalence reported in previous surveys is reported. Re­sults. Hypoalphalipoproteinemia and elevated LDL-C are the most prevalent dyslipidemias in Mexican adults. One in four adults had hypercholesterolemia at the moment of the interview without previous diagnosis. Awareness, treatment and control of dyslipidemia were 12.6, 3.7 and 3.1%, respec­tively. Conclusions. Dyslipidemias are the most prevalent risk factor for cardiovascular diseases in Mexico. Public poli­cies to increase awareness, access to therapy and sustained control are urgently needed.